Bond And Money Market

We present a matrix detailing some movement in some key market rates (domestic and global) and key events:

Parameters 30-June-21 31-May-21 30-June-20
RBI Repo Rate % 4.00 4.00 4.00
5Y AAA PSU % 6.40 6.27 5.69
1 year CD % 4.16 4.15 4.05
10Y Gsec % 6.05 6.02 5.89
CPI (%) 6.30 4.29 6.27
IIP (FYTD) % 134.44 24.15 -57.31
US 10Y % 1.47 1.59 0.66
Dollar Rupee 74.33 72.61 75.51

Source: Bloomberg; Data as on June 30th, 2021

It was a month of the MPC meeting; all the policy rates were kept unchanged. The undertone of the policy continued to be very dovish with a clear priority to foster growth. The RBI also lowered the growth projections to 9.50% for the current fiscal year and raised the inflation forecasts marginally. It also announced a continued program of buying of Government Bonds through the GSAP 2.0. .

While the RBI continued to maintain a dovish undertone, the debt markets drifted with an upward bias. The markets have largely been unsettled by the higher inflation readings and the possibility of enhanced borrowing by the Central Government. While the 10-year rates moved up marginally, the 3-5-year G-Sec and corporate bond rates moved by around 15-25 basis points, resulting to flattening of the term structure of the yield curve. With liquidity remaining comfortable, the money market rates broadly remained unchanged.

Looking Ahead
  • The RBI continues to remain the beacon of hope for the domestic debt markets. The surge in pandemic domestically has also put the markets to believe that the MPC will continue to remain dovish as it would continue to focus on growth and would ignore inflation as a transient phenomenon.
  • However, we remain apprehensive of a gradual rate rise as we move through the year. We believe that the markets may stop coat tailing the RBI, and are not ignoring a commodity prices rise induced inflation and a larger borrowing program
  • The possibility of a bear flattening of the yield curve exists with long term rates rising lesser than short term rates
  • We also believe that AAA credit spreads are very tight and the probability of spreads to increase in the near future remains a distinct possibility
  • Liquidity being in sustained surplus mode, the extreme short end of the yield curve may remain stable.
Scheme Specific Strategies for Debt schemes
  • Mahindra Manulife Low Duration Fund
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 140 days
    • We will maintain the maturity as we move ahead through the next month
    • The YTM of the portfolio is around 4.12%
    • With surplus liquidity conditions we expect the extreme short-end money market rates to remain benign
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
  • Mahindra Manulife Dynamic Bond Yojana
    • The YTM of the portfolio has decreased to around 5.86%.
    • The Modified Duration of the portfolio (MD) is around 3.98 years
    • While we have increased the duration in the portfolio, we intend now to remain steady at these levels
    • We are likely to continue with the non AAA credits carrying near term maturities in our portfolio till maturities and consider replacing them preferably with high quality debt instruments.
  • Mahindra Manulife Short Term Fund
    • The YTM of the portfolio is around 5.09%
    • The Modified duration of the portfolio increased to 1.85 years
    • Our portfolio continues to have a large allocation towards gilts as we are wary of the tight spreads in AAA credits.
Equity Market Outlook

We present a summary of changes in key Indian & Global equity indices


S&P BSE Sensex Nifty 50 BSE Midcap BSE Small Cap Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance 1.0% 0.9% 3.6% 6.9% 4.6% 5.0% -0.1% 2.2% 5.5%
1 Yr Performance 50.3% 52.6% 72.6% 103.8% 83.4% 110.9% 33.7% 38.6% 44.2%

Source: Bloomberg Performance - Absolute returns | Data as on June 30, 2021

Equity Market Update

Indian markets continued with the broad-based rally in previous month with the mid- and small-cap indices faring better than Nifty. The broad rationale for the market behaviour is the increasing retail participation in equity markets. From the perspective of institutional investors as well, hopes of cyclical recovery brings earning growth expectations in small and mid-caps. Among large sectors in market; IT, Pharma, FMCG outperformed, while Financials, Energy underperformed Nifty.

Globally, the equity markets continue to remain in positive zone. The market expectations regarding economic recovery is that it is on track, driven by normalization in services activity as US and Europe get vaccinated. Outcome of US Federal Reserve policy meet reiterated Fed’s view of current high inflation being transitory and hence the willingness to accept the current level. Fed policy also signaled marginally quicker tightening versus expectations before the meeting. While the roadmap on expected rate hike is shared by Fed through “dot plot”, the review and dis-continuation of bond purchase (liquidity infusion) is a known unknown.

When the global economy was hit in March 2020, US Fed acted on monetary stimulus to support economy. Majority of central banks across the globe followed with a similar policy action. Once the expectations about Fed plan for taper is known, how other central banks react would be key. In some emerging markets, central banks have already started their path of rate hike to control inflation.

We would monitor policy action by RBI in India’s context. While higher bond yields can act as headwinds to the equity markets through higher cost of equity, policy action on withdrawing liquidity support can impact the economic growth and portfolio construct. Historical experiences suggest that monetary easing supports mid and small-cap segments in general, while tightening hurts these segments. Primary rationale being that many small and mid-cap companies are capital starved and easy liquidity helps them in business activities. Definitely, this applies more to companies that rely on external financing and to that extent company specific analysis continues to remain the primary driver of portfolio construct.

On Covid front, while US and Europe are ahead on vaccination as a % of population, Indian government is moving on track for Dec 2021 target of getting substantial population vaccinated. India vaccinated over 8 million citizens on a single day in June and while we write this, India has overtaken in terms of total vaccinations done. As supply dynamics improve through new vaccines, domestic as well as global, the normalization of activities will pick pace.

Looking Ahead

Globally, the monetary policy response to inflation in post-vaccinated economy remains the focus area for financial markets. The key reason being that ultra-low interest rates have led investors to look at higher valuations as a new normal. The investor reaction to higher policy rates would be a true test of the sustainability of higher valuations. Specific to US, the fiscal support by way of direct payment and unemployment benefits comes to an end on September 6th 2021. Policy decision on further continuation is also a variable that is likely to influence consumer demand and economic growth in US.

The result season for Q1FY22 would be interesting to follow for management commentary for FY22. In a way, the current year is likely to replicate FY21 wherein post the Covid disturbance in Q1 the economy normalised during the festive season in Q3. There are already demands for some fresh measures to support MSMEs and Lenders, with policy makers announcing extension of credit guarantees.

While the power of asset allocation to equity in past 12-15 months has been seen, it is equally, if not more important to realize the power of market cycles in terms of capitalizations. What started as a large-cap driven recovery, passed leadership baton to mid-cap and then to small-caps. The economic cycle of growth and corporate earnings, navigate across market capitalization, driven by policy actions on both fiscal and monetary front. We believe this re-emphasises the need to be flexible in choosing companies across market capitalizations. Yes, there are clearly Risks (Uncertainty) in Markets and its relationship with expected Returns. Large Cap, Mid Cap and Small Cap as a segment, play a critical role in portfolio construction for investors and they may choose to manage it themselves or choose to entrust to funds who have the flexible approach.

Investors with lumpsum investments could have an asset allocation strategy (equity as a % of portfolio) to try and benefit from greed and fear phases. Alternatively, the strategy is to really stick to longer term outlook rather than focusing on 1-2 years volatility. However, for investors with SIP investments such phases are not so relevant as investor is still in accumulation phase for wealth creation over the 5-7 years. SIP may be a good alternate to avoid the behavioural traps during the extreme phases of markets. We maintain that investors use SIP as part of core investment philosophy and use the lumpsum route to top-up on their SIPs in fearful times amid market volatility.

Source: Bloomberg

Scheme Specific Strategies for Equity schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
  • Mahindra Manulife ELSS Kar Bachat Yojana
  • Mahindra Manulife Rural Bharat and Consumption Yojana
  • Mahindra Manulife Large Cap Pragati Yojana
  • Mahindra Manulife Top 250 Nivesh Yojana
  • Mahindra Manulife Focused Equity Yojana
Scheme Specific Strategies For Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.

    Debt:

    • The Modified duration of the portfolio is around 2.94 years for the debt portion
    • We intend to have a portfolio with a larger allocation towards gilts as we move ahead.
What should an investor do?

For investments in debt oriented products:

  • We believe that the investors with a shorter investment horizon may continue investments in ultra-short term and low duration funds
  • For a medium to long term investment horizon and with a suitable risk appetite, an allocation to short term fund and dynamic bond fund merits attention.

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • Investors looking to invest for a medium to long period, can consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in mid capfundas well.
Scheme Name Product Suitability Riskometer
Mahindra Manulife Overnight Fund
An open ended debt scheme investing in overnight securities
This Product is suitable for investors who are seeking*:
  • To generate reasonable returns with high levels of safety and convenience of liquidity over short term
  • To invest in debt and money market instruments having maturity of upto 1 business day
Mahindra Manulife Arbitrage Yojana
An open ended scheme investing in arbitrage opportunities
This Product is suitable for investors who are seeking*:
  • Income over short term
  • Income through arbitrage opportunities between cash and derivative market and arbitrage opportunities within the derivative segment.
Mahindra Manulife Liquid Fund
An Open Ended Liquid scheme
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
Mahindra Manulife Short Term Fund
An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years (please refer to page no. 35 of SID)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
Mahindra Manulife Low Duration Fund
An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months (Please refer page 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in debt and money market instruments
Mahindra Manulife Ultra Short Term Fund
An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months (please refer to page no. 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
Mahindra Manulife Dynamic Bond Yojana
An open ended debt scheme investing across duration 
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation through active management of portfolio
  • Investments in debt & money market instruments across duration.
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
An open ended scheme investing in equity, arbitrage and debt
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments
Mahindra Manulife ELSS Kar Bachat Yojana
An open ended equity linked saving scheme with a statutory lock in of 3 years and tax benefit
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities
Mahindra Manulife Focused Equity Yojana
An open ended equity scheme investing in maximum 30 stocks across market caps (i.e Multi Cap)
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation.
Mahindra Manulife Top 250 Nivesh Yojana
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and Mid cap companies.
Mahindra Manulife Multi Cap Badhat Yojana
Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives.
Mahindra Manulife Mid Cap Unnati Yojana
Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies
Mahindra Manulife Large Cap Pragati Yojana
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Mahindra Manulife Hybrid Equity Nivesh Yojana
An open ended hybrid scheme investing predominantly in equity and equity related instruments
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income;
  • Investment in equity and equity related instruments and debt and money market instruments
Mahindra Manulife Rural Bharat and Consumption Yojana
An open ended scheme following Rural India theme
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/ or expected to benefit from the growth in rural India.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno.00983

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.